Cargando…

PS15. Can gene therapy treat anxiety? – Overexpression of Neuropeptide S using adeno-associated viral vectors

Detalles Bibliográficos
Autores principales:	Tillmann, S, Elbrønd-Bek, H, Gøtzsche, CR, Christiansen, SH, Mathé, AA, Woldbye, DP, Wegener, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616614/ http://dx.doi.org/10.1093/ijnp/pyw043.015

Ejemplares similares

MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro
por: Wei, Ya Bin, et al.
Publicado: (2016)

Disease Modification by Combinatorial Single Vector Gene Therapy: A Preclinical Translational Study in Epilepsy
por: Melin, Esbjörn, et al.
Publicado: (2019)

Activation of Neuropeptide Y Receptors Modulates Retinal Ganglion Cell Physiology and Exerts Neuroprotective Actions In Vitro
por: Martins, João, et al.
Publicado: (2015)

Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy: Preclinical Data in Rats
por: Szczygieł, Julia Alicja, et al.
Publicado: (2020)

Adeno-Associated Viral Vectors in Neuroscience Research
por: Haggerty, David L., et al.
Publicado: (2019)

Neuropeptide y and neuropeptide s in major depressive disorder and post-traumatic stress disorder: Preclinical andclinical studies
por: Mathe, A.
Publicado: (2021)

Molecular evolution of neuropeptides in the genus Drosophila
por: Wegener, Christian, et al.
Publicado: (2008)

Novel Cytotoxic Vectors Based on Adeno-Associated Virus
por: Kohlschütter, Johannes, et al.
Publicado: (2010)

Production and Titering of Recombinant Adeno-associated Viral Vectors
por: McClure, Christina, et al.
Publicado: (2011)

Accurate Quantification and Characterization of Adeno-Associated Viral Vectors
por: Dobnik, David, et al.
Publicado: (2019)

Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
por: Jensen, Thomas Leth, et al.
Publicado: (2021)

Neuropeptide Y in Alcohol Addiction and Affective Disorders
por: Thorsell, Annika, et al.
Publicado: (2017)

Adeno-associated virus: from defective virus to effective vector
por: Gonçalves, Manuel AFV
Publicado: (2005)

Axonal transport of adeno-associated viral vectors is serotype-dependent
por: Salegio, Ernesto A., et al.
Publicado: (2012)

Biology of adeno-associated viral vectors in the central nervous system
por: Murlidharan, Giridhar, et al.
Publicado: (2014)

Manufacturing of recombinant adeno-associated viral vectors for clinical trials
por: Clément, Nathalie, et al.
Publicado: (2016)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors
por: Bates, Rhiannon, et al.
Publicado: (2020)

Production of adeno-associated virus vectors for in vitro and in vivo applications
por: Kimura, Toyokazu, et al.
Publicado: (2019)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
por: Li, Leyao, et al.
Publicado: (2023)

Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
por: Rossi, Axel, et al.
Publicado: (2019)

Lentiviral Vectors and Adeno‐Associated Virus Vectors: Useful Tools for Gene Transfer in Pain Research
por: Zheng, Chen‐Xi, et al.
Publicado: (2018)

The state of the art of adeno-associated virus-based vectors in gene therapy
por: Coura, Renata dos Santos, et al.
Publicado: (2007)

Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors
por: Craig, Anthony T, et al.
Publicado: (2009)

Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome
por: Ayuso, Eduard
Publicado: (2016)

Perinatal systemic gene delivery using adeno-associated viral vectors
por: Karda, Rajvinder, et al.
Publicado: (2014)

Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering
por: Sen, Dwaipayan
Publicado: (2014)

A simplified purification protocol for recombinant adeno-associated virus vectors
por: Potter, Mark, et al.
Publicado: (2014)

In Situ Detection of Adeno-associated Viral Vector Genomes with SABER-FISH
por: Wang, Sean K., et al.
Publicado: (2020)

Capsid-specific removal of circulating antibodies to adeno-associated virus vectors
por: Bertin, Berangere, et al.
Publicado: (2020)

GABAergic Gene Regulatory Elements Used in Adeno-Associated Viral Vectors
por: Duba-Kiss, Robert, et al.
Publicado: (2021)

Differential T cell immune responses to deamidated adeno-associated virus vector
por: Bing, So Jin, et al.
Publicado: (2022)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Retrograde capabilities of adeno-associated virus vectors in the central nervous system
por: Surdyka, Magdalena M., et al.
Publicado: (2021)

Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors
por: Chai, Sunghee, et al.
Publicado: (2023)

Modifying immune responses to adeno-associated virus vectors by capsid engineering
por: Bentler, Martin, et al.
Publicado: (2023)

Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies
por: Ledri, Marco, et al.
Publicado: (2021)

Neuroglobin deficiency increases seizure susceptibility but does not affect basal behavior in mice
por: Gøtzsche, Casper R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mm7mvjc2u0cje12fopv37314ui